{
    "code": "12000817",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12000817",
    "time": "2021-11-26 06:04:37",
    "許可證字號": "內衛藥製字第000817號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/05\/25",
    "發證\/登錄日期": "58\/06\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY01200081703",
    "中文品名": "癲能停膠囊",
    "英文品名": "DILANTIN KAPSEALS",
    "適應症": "大發作及局部發作形癲癇，預防及治療神經外科手術所引起之癲癇發作。",
    "劑型": "130膠囊劑",
    "包裝": "6-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PHENYTOIN SODIUM",
    "限制項目": "01國　產",
    "申請商名稱": "620117S703  暉致醫藥股份有限公司",
    "申請商地址": "臺北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司(委託包裝)",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812000610",
            "成分名稱": "PHENYTOIN SODIUM",
            "含量描述": "100.00",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "鮮紅橙\/白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "PARKE,DAVIS",
        "標記二": "P-D,100"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Dilantin 實體外觀-104-09-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=440&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Dilantin CDS20181019-2-110-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=014&Type=9"
        },
        {
            "title": "Dilantin Kapseals LLD CDS 20181019-1-108-04-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=013&Type=9"
        },
        {
            "title": "癲能停膠囊_仿單-107-11-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=012&Type=9"
        },
        {
            "title": "02 000817 0001-106-11-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=011&Type=9"
        },
        {
            "title": "癲能停膠囊_內衛藥製字第000817號_仿單-106-08-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=010&Type=9"
        },
        {
            "title": "Dilantin Kapseals LLD CDS 20160615-1-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=009&Type=9"
        },
        {
            "title": "Dilantin Kapseals LLD CDS 20151119-2-105-07-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=008&Type=9"
        },
        {
            "title": "Dilantin瓶裝包裝-110-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=003&Type=8"
        },
        {
            "title": "Dilantin 外包裝_new site name-104-12-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12000817&Seq=002&Type=8"
        }
    ]
}